Meeting
2016 ASCO Annual Meeting
A phase 1 trial of vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced stage head and neck squamous cell carcinoma.
Authors
Theodoros Nicholas Teknos
The James Cancer Hospital Ohio State University, Columbus, OH
Theodoros Nicholas Teknos , Matthew Owen Old , John C. Grecula , Amit Agrawal , Enver Ozer , Ricardo Carrau , Stephan Kang , James William Rocco , Dukagjin Blakaj , Virginia Diavolitsis , Robert A. Baiocchi , Bhavna Kumar , Panayiotis Savvides
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT01064921
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6036)
DOI
10.1200/JCO.2016.34.15_suppl.6036
Abstract #
6036
Poster Bd #
358
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Phase I study of vorinostat with concurrent chemoradiotherapy (CRT) for locally advanced non-squamous non-small cell lung cancer (NSCLC).
First Author: Ranee Mehra
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2020 ASCO Virtual Scientific Program
Phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with an anti-PD-1 therapy.
First Author: Colette Shen